Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), which is a validated instrument that assesses the functional status and the disease progression in patients with amyotrophic lateral sclerosis (ALS), predicts hospital length of stay and survival time in ALS patients treated with tracheostomy-intermittent positive-pressure ventilation (TIPPV). Methods: Thirty-three consecutive ALS patients with acute respiratory failure who received therapy with TIPPV were prospectively followed up from their admission to the hospital until death. The association of ALSFRS score at hospital admission with length of hospital stay and survival after TIPPV were examined using Cox proportional hazard models, adju...
BACKGROUND: The most frequent cause of death in patients with Amyotrophic Lateral Sclerosis (ALS) is...
The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure i...
Contains fulltext : 176941.pdf (publisher's version ) (Open Access)BACKGROUND: Non...
Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), ...
Abstract Forced vital capacity (FVC) shows limitations in detecting respiratory failure in the ea...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
Background: Acute respiratory failure (ARF) is a common event in the advanced stage of amyotrophic l...
Objective: The choice of adequate proxy for long-term survival, the ultimate outcome in randomised c...
© 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights r...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
Objective: To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to anal...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Background and purpose: Forced vital capacity (FVC) <80% is one of the key indications for starti...
Objective: To identify factors associated with tolerance and survival after noninvasive positive-pre...
BACKGROUND: The most frequent cause of death in patients with Amyotrophic Lateral Sclerosis (ALS) is...
The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure i...
Contains fulltext : 176941.pdf (publisher's version ) (Open Access)BACKGROUND: Non...
Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), ...
Abstract Forced vital capacity (FVC) shows limitations in detecting respiratory failure in the ea...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
Background: Acute respiratory failure (ARF) is a common event in the advanced stage of amyotrophic l...
Objective: The choice of adequate proxy for long-term survival, the ultimate outcome in randomised c...
© 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights r...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
Objective: To report the latest long-term outcome of amyotrophic lateral sclerosis (ALS) and to anal...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Background and purpose: Forced vital capacity (FVC) <80% is one of the key indications for starti...
Objective: To identify factors associated with tolerance and survival after noninvasive positive-pre...
BACKGROUND: The most frequent cause of death in patients with Amyotrophic Lateral Sclerosis (ALS) is...
The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure i...
Contains fulltext : 176941.pdf (publisher's version ) (Open Access)BACKGROUND: Non...